Major owner of AMAG Pharmaceuticals just picked up 1,100 shares

Capital Partners Adage, a major owner of AMAG Pharmaceuticals, recently acquired 1,100 shares of the company. The buys took place at $23.50 per share, on August 06, 2013. Adage now owns 3,904,192 shares of the company. Adage operates out of Boston, MA. Some additional info was provided as follows:

Adage Capital Partners GP, L.L.C., a Delaware limited liability company ("ACPGP"), serves as the general partner of Adage Capital Partners, L.P., a Delaware limited partnership (the "Fund"), and as such has discretion over the portfolio securities beneficially owned by the Fund. Adage Capital Advisors, L.L.C., a Delaware limited liability company ("ACA"), is the managing member of ACPGP and directs ACPGP's operations. Robert Atchinson and Phillip Gross are the managing members of ACPGP and ACA and general partners of the Fund. ACPGP, ACA, Robert Atchinson and Phillip Gross disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever AMAG Pharmaceuticals makes a similar move, sign up!

Other recent filings from the company include the following:

AMAG Pharmaceuticals just filed a General Statement of acquisition of beneficial ownership - April 16, 2014
AMAG Pharmaceuticals director just declared 0 ownership of the company. - April 16, 2014
Amag Pharmaceuticals Announces Appointment Of Jim Sulat To Its Board Of Directors - April 16, 2014
AMAG Pharmaceuticals director just picked up 192 shares - April 16, 2014
AMAG Pharmaceuticals director just disposed of 2,500 shares - April 16, 2014

   Auto Refresh

Feedback